查看分析师 EPS 与营收区间、覆盖人数，以及过去 7、30、90 天的预期变化。缺失修正不会显示成零；分析师人数较少的公司默认不进入排名。
| 公司 | 财年 EPS | 预期区间 | 分析师 | 7 日 | 30 日 | 90 日 | 30 日上调 / 下调 | 营收预期 |
|---|---|---|---|---|---|---|---|---|
| AVTR Avantor Inc. Common Stock | 0.81 2026-12-31 | 0.8 – 0.83 | 16 | +2.96% | +2.91% | +2.84% | 5 / 5 | $6.59B |
| AVAH Aveanna Healthcare Holdings Inc. Common Stock | 0.71 2026-12-31 | 0.66 – 0.75 | 11 | 0.00% | +0.84% | +13.76% | 11 / 0 | $2.63B |
| NAVN Navan Inc. Class A Common Stock | 0.25 2027-01-31 | 0.2 – 0.31 | 12 | +0.33% | +0.33% | — | 12 / 0 | $911.2M |
| AVA Avista Corporation Common Stock | 2.6 2026-12-31 | 2.52 – 2.65 | 7 | 0.00% | +0.11% | +0.56% | 0 / 1 | $1.99B |
| DAVA Endava plc American Depositary Shares (each representing one Class A Ordinary Share) | 0.46 2026-06-30 | 0.45 – 0.48 | 8 | 0.00% | 0.00% | -43.00% | 0 / 7 | $723.09M |
| CAVA CAVA Group Inc. Common Stock | 0.55 2026-12-31 | 0.49 – 0.6 | 24 | -0.57% | -0.74% | +5.20% | 20 / 3 | $1.5B |
| AVAV AeroVironment Inc. Common Stock | 3.24 2027-04-30 | 3.04 – 3.44 | 19 | +0.11% | -19.13% | -20.04% | 2 / 12 | $2.19B |
| AVTX Avalo Therapeutics Inc. Common Stock | -2.56 2026-12-31 | -3.53 – -1.77 | 11 | — | — | — | 5 / 0 | $0 |
| MRVI Maravai LifeSciences Holdings Inc. Class A Common Stock | -0.11 2026-12-31 | -0.17 – -0.06 | 8 | — | — | — | 2 / 0 | $210.43M |
| NVAX Novavax Inc. Common Stock | -0.47 2026-12-31 | -1.38 – 0.52 | 9 | — | — | — | 1 / 6 | $409.97M |
| SVRA Savara Inc. Common Stock | -0.58 2026-12-31 | -0.69 – -0.53 | 5 | — | — | — | 0 / 3 | $2.55M |
默认至少 3 位分析师。没有历史值、EPS 非正值或历史 EPS 过于接近零时显示“—”，不会用失真的百分比参与排名。
榜单优先使用当前财年 EPS；营收修正由每日快照逐步积累，首日不会生成伪历史。